Evidence map›Paper›PMID 18621733›Full record

ArticleThe Journal of biological chemistry2008

Differential roles of phosphatidylserine, PtdIns(4,5)P2, and PtdIns(3,4,5)P3 in plasma membrane targeting of C2 domains. Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKCalpha C2 domain.

Debasis Manna, Nitin Bhardwaj, Mohsin S Vora, Robert V Stahelin, Hui Lu, Wonhwa Cho

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 80 citations in OpenAlex.

  1. CaThe journal of physical chemistry. B · 2025
    Article
  2. Article
  3. Article
  4. Binding of CaStructure (London, England : 1993) · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Debasis MannaDepartment of Bioengineering, University of Illinois, Chicago, Illinois 60607, USA.
Nitin Bhardwaj
Mohsin S Vora
Robert V Stahelin
Hui Lu
Wonhwa Cho
University of Illinois Chicago · USIndiana University · USUniversity of Notre Dame · US

Funding

Protein Expression and PurificationP01AI060915 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JOHNSON, MICHAEL E. · 2005 to 2009
$7.7M
Membrane Targeting by Phosphoinositide-Binding ProteinsR01GM068849 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHO, WONHWA · 2003 to 2015
$3.9M
Studies of Eicosanoid Biosynthetic ProteinsR01GM052598 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHO, WONHWA · 1996 to 2013
$3.7M
Studies of Diacylglycerol-Binding ProteinsR01GM076581 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHO, WONHWA · 2006 to 2009
$1.1M
NIAID NIH HHS P01AI060915NIGMS NIH HHS GM52598NIGMS NIH HHS GM68849NIGMS NIH HHS GM76581
6 · The paper itself

Abstract

Many cytosolic proteins are recruited to the plasma membrane (PM) during cell signaling and other cellular processes. Recent reports have indicated that phosphatidylserine (PS), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P(2)), and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P(3)) that are present in the PM play important roles for their specific PM recruitment. To systematically analyze how these lipids mediate PM targeting of cellular proteins, we performed biophysical, computational, and cell studies of the Ca(2+)-dependent C2 domain of protein kinase Calpha (PKCalpha) that is known to bind PS and phosphoinositides. In vitro membrane binding measurements by surface plasmon resonance analysis show that PKCalpha-C2 nonspecifically binds phosphoinositides, including PtdIns(4,5)P(2) and PtdIns(3,4,5)P(3), but that PS and Ca(2+) binding is prerequisite for productive phosphoinositide binding. PtdIns(4,5)P(2) or PtdIns(3,4,5)P(3) augments the Ca(2+)- and PS-dependent membrane binding of PKCalpha-C2 by slowing its membrane dissociation. Molecular dynamics simulations also support that Ca(2+)-dependent PS binding is essential for membrane interactions of PKCalpha-C2. PtdIns(4,5)P(2) alone cannot drive the membrane attachment of the domain but further stabilizes the Ca(2+)- and PS-dependent membrane binding. When the fluorescence protein-tagged PKCalpha-C2 was expressed in NIH-3T3 cells, mutations of phosphoinositide-binding residues or depletion of PtdIns(4,5)P(2) and/or PtdIns(3,4,5)P(3) from PM did not significantly affect the PM association of the domain but accelerated its dissociation from PM. Also, local synthesis of PtdIns(4,5)P(2) or PtdIns(3,4,5)P(3) at the PM slowed membrane dissociation of PKCalpha-C2. Collectively, these studies show that PtdIns(4,5)P(2) and PtdIns(3,4,5)P(3) augment the Ca(2+)- and PS-dependent membrane binding of PKCalpha-C2 by elongating the membrane residence of the domain but cannot drive the PM recruitment of PKCalpha-C2. These studies also suggest that effective PM recruitment of many cellular proteins may require synergistic actions of PS and phosphoinositides.

Indexed as

Gene Expression Regulation, EnzymologicAnimalsBiophysicsCell MembraneCell MovementMiceMutationNIH 3T3 CellsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesPhosphatidylserinesProtein BindingProtein Kinase C-alphaProtein Structure, TertiaryProtein Transportphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesPhosphatidylserinesProtein Kinase C-alpha

Identifiers

PMID18621733
PMCPMC2533782
OpenAlexW1996410160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.